Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V95.2.410PMID 10627443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized Comparison of Interferon-a With Busulfan and Hydroxyurea in Chronic Myelogenous Leukemia

  2002cited by this paper
• The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phrase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure.

  1999influential reference
• Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.

  1998influential reference
• Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase

  1998cited by this paper
• Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.

  1998cited by this paper
• Initial therapy for chronic myelogenous leukemia: playing the odds.

  1998influential reference
• Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.

  1997influential reference
• Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.

  1997cited by this paper
• Survival Analysis: Techniques for Censored and Truncated Data

  1997influential reference
• Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.

  1997cited by this paper
• Unrelated Donor Bone Marrow Transplantation for Chronic Myelogenous Leukemia: A Decision Analysis

  1997influential reference
• Treatment of Chronic Myelogenous Leukemia: Current Status and Investigational Options

  1996influential reference
• Treatment of myelogenous leukemia: current status and investigational options.

  1996cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia.

  1995cited by this paper
• Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome.

  1995cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

  1995influential reference
• Score test of homogeneity for survival data

  1995influential reference
• Bone marrow transplantation for chronic myelogenous leukemia [letter; comment]

  1994cited by this paper
• Management of chronic myeloid leukaemia.

  1994influential reference
• Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.

  1994influential reference
• Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia.

  1994cited by this paper
• Chronic myelogenous leukemia: a concise update.

  1993cited by this paper
• Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase.

  1993cited by this paper
• Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.

  1993cited by this paper
• Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase

  1993cited by this paper
• Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2.

  1992influential reference
• The interferons. Mechanisms of action and clinical applications.

  1991influential reference
• Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.

  1991influential reference
• Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation.

  1990influential reference
• Risk factors for acute graft‐versus‐host disease

  1987influential reference
• Marrow transplantation for the treatment of chronic myelogenous leukemia.

  1986influential reference
• Bone marrow transplantation for patients with chronic myeloid leukemia.

  1986influential reference
• Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.

  1986influential reference
• ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA

  1984influential reference
• Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin.

  1979influential reference

• Allogeneic Stem Cell Transplantation for Pediatric and Adolescent Patients with CML: Results from the Prospective Trial CML-paed I

  2009cites this paper
• Allogeneic Unrelated Donor Blood and Marrow Transplantation

  2008cites this paper
• Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia

  2008cites this paper
• urrent Therapy of Chronic Myelogenous Leukemia

  2007cites this paper
• Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning

  2007cites this paper
• Allogeneic Transplantation for CML

  2007cites this paper
• Chronic myeloid leukemia: diagnosis and treatment.

  2006cites this paper
• Cytogenetic response to prior treatment with interferon-α is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia

  2006cites this paper
• Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment.

  2005cites this paper
• Personalized medical treatment strategies for patients with chronic myeloid leukemia

  2005cites this paper
• Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia

  2004cites this paper
• Interferon alpha (IFN) treatment of bone marrow stroma inhibits haematopoesis.

  2004cites this paper
• Chronic myeloid leukemia: current status and controversies.

  2004cites this paper
• Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia.

  2004cites this paper
• Optimizing treatment of chronic myeloid leukemia: a rational approach.

  2004cites this paper
• Role of pretransplant interferon-α(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers

  2003cites this paper
• Biologic Therapy of Leukemia

  2003cites this paper
• Transplantation for chronic myelogenous leukemia: yes, no, maybe so…an Oregon perspective

  2003cites this paper
• Chronic myelogenous leukemia: A review and update of therapeutic strategies

  2003cites this paper
• Sudden onset of the blastic phase of chronic myelogenous leukemia

  2003cites this paper
• Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias

  2003cites this paper
• Interferon-alfa for chronic myeloid leukemia.

  2003cites this paper
• Stem cell transplantation for chronic myeloid leukemia in children.

  2003cites this paper
• Allogeneic hematopoietic stem cell transplantation for myeloproliferative disorders and myelodysplastic syndromes.

  2003cites this paper
• Chronic leukemias and lymphomas : biology, pathophysiology, and clinical management

  2002cites this paper
• Current therapy of chronic myelogenous leukemia.

  2002cites this paper
• Chronic myelogenous leukemia.

  2002cites this paper
• Prior treatment with alpha interferon does not adversely 
affect the outcome of allogeneic transplantation 
for chronic myeloid leukaemia

  2002influential citation
• Allogeneic transplantation for leukaemia using unrelated donors.

  2001cites this paper
• Chronic myeloid leukaemia

  2001influential citation
• The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.

  2001cites this paper
• Chronic myelogenous leukemia.

  2001cites this paper
• The biology and treatment of chronic myelogenous leukemia.

  2001cites this paper
• Dose‐reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis

  2001influential citation
• Unrelated donor hematopoietic transplantation.

  2001cites this paper
• Reconstitution of the CD45RO+ and CD20+ lymphoid marrow population following allogeneic bone marrow transplantation for Ph+ CML

  2001cites this paper
• Síndromes mieloproliferativos. Leucemia mieloide crónica

  2001cites this paper
• Interferon- α should be discontinued at least 90 days before bone marrow transplantation for chronic myelogenous leukemia

  2001cites this paper
• NCCN Practice Guidelines for Chronic Myelogenous Leukemia.

  2000cites this paper
• Trial of IFN or STI571 before proceeding to allografting for CML?

  2000cites this paper
• HEMATOLOGICAL ONCOLOGY

  2000cites this paper
• CHRONIC MYELOGENOUS LEUKAEMIA

  2000influential citation
• Therapeutic choices in younger patients with chronic myelogenous leukemia

  2000cites this paper
• Stem Cell Transplantation for Chronic Myeloid Leukemia

  2000cites this paper
• TRANSPLANTE DE MEDULA ÓSSEA NA LEUCEMIA MIELÓIDE CRÔNICA

  2000cites this paper
• Chronic Myelogenous Leukemia (CML)

  1999cites this paper
• Chronic myeloid leukemia.

  1999cites this paper